InnoCan Pharma (INNO) Financial Statements

22 Followers

InnoCan Pharma Financial Overview

InnoCan Pharma's market cap is currently C$29.96M. The company's EPS TTM is C$0.618; its P/E ratio is -19.43; InnoCan Pharma is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Mar 24	Dec 22	Mar 22
Income Statement
Total Revenue	$ 26.61M	$ 29.44M	$ 13.66M	$ 2.56M	$ 196.00K
Gross Profit	$ 23.93M	$ 26.19M	$ 11.98M	$ 2.11M	$ 121.00K
Operating Income	$ -1.25M	$ -1.25M	$ 3.80M	$ -6.27M	$ -7.48M
EBITDA	$ 130.00K	$ 961.00K	$ -3.77M	$ -3.85M	$ -10.04M
Net Income	$ -1.12M	$ -1.83M	$ -4.70M	$ -3.89M	$ -10.06M
Balance Sheet
Cash & Short-Term Investments	$ 6.69M	$ 5.01M	$ 3.88M	$ 4.95M	$ 11.05M
Total Assets	$ 10.52M	$ 9.26M	$ 6.94M	$ 6.98M	$ 12.57M
Total Debt	$ 930.00K	$ 10.00K	$ 33.00K	$ 34.00K	$ 1.00K
Net Debt	$ -5.76M	$ -5.00M	$ -3.85M	$ -4.91M	$ -11.05M
Total Liabilities	$ 2.29M	$ 2.24M	$ 2.55M	$ 751.00K	$ 3.56M
Stockholders' Equity	$ 5.60M	$ 5.17M	$ 4.10M	$ 6.39M	$ 9.05M
Cash Flow
Free Cash Flow	$ 479.00K	$ -1.59M	$ -3.95M	$ -6.09M	$ -6.67M
Operating Cash Flow	$ 495.00K	$ -1.58M	$ -3.90M	$ -6.07M	$ -6.63M
Investing Cash Flow	$ -15.00K	$ 54.00K	$ -84.00K	$ -31.00K	$ -48.00K
Financing Cash Flow	$ 1.15M	$ 2.70M	$ 2.92M	$ 125.00K	$ 15.30M

Currency in USD

InnoCan Pharma Earnings and Revenue History

Income Statement >

InnoCan Pharma Debt to Assets

Balance Sheet >

InnoCan Pharma Cash Flow

Cash Flow >

InnoCan Pharma Forecast EPS vs Actual EPS

Earnings >